REPROS THERAPEUTICS INC. $10,000,000 of Common Stock ($0.001 par value per share) Equity Distribution AgreementEquity Distribution Agreement • August 9th, 2016 • Repros Therapeutics Inc. • Biological products, (no disgnostic substances) • New York
Repros Therapeutics Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Ladenburg Thalmann & Co. Inc. (“Ladenburg”), as follows:
